Aebi Schmidt
AEBI
11.02
-0.01
-0.09%
Aebi Schmidt
US · AEBI
#3366 by market cap
Listed 2025
11.02
-0.01
-0.09%
Live - 5344 symbols - heartbeat 107s ago
· 2026-10-09 19:30
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.60, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 3 years
Latest year +40.58% YoY
Margins
- Gross margin
- 19.92%
- Operating margin
- 4.79%
- Net margin
- 0.64%
Key ratios & quality
- Enterprise valuei
- 1.37B
- Altman Z-Scorei
- 1.60
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 1.02B | 1.09B | 1.53B |
| Gross profit | 206.65M | 228.24M | 304.05M |
| Selling & admin expenses | 117.06M | 124.66M | 180.65M |
| Research & development | 17.13M | 19.56M | 26.49M |
| Operating profit | 59.03M | 68.49M | 73.07M |
| Pretax profit | 17.35M | 41.66M | 11.19M |
| Tax | 6.15M | 10.93M | 1.49M |
| Net profit | 11.20M | 30.74M | 9.71M |
| Basic EPS | 0 | 0 | 0 |
| Diluted EPS | 0.14 | 0.40 | 0.17 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 249.19M | 277.74M | 471.33M | 528.37M | 455.55M | 496.41M |
| Gross profit | 53.31M | 56.83M | 94.11M | 99.80M | 87.39M | 97.29M |
| Selling & admin expenses | 30.72M | 33.57M | 59.30M | 57.05M | 58.55M | 55.70M |
| Research & development | 4.63M | 5.43M | 8.74M | 7.70M | 6.70M | 6.44M |
| Operating profit | 14.39M | 13.86M | 17.50M | 27.32M | 15.37M | 27.04M |
| Pretax profit | 2.85M | -3.21M | 747.00K | 10.81M | 1.16M | 15.32M |
| Tax | 787.00K | -890.00K | -447.00K | 2.04M | 488.00K | 4.85M |
| Net profit | 2.06M | -2.32M | 1.19M | 8.77M | 671.00K | 10.47M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.03 | -0.03 | 0.02 | 0.15 | 0.01 | 0.14 |
Balance sheet
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total current assets | 520.13M | 518.16M | 877.73M |
| Cash & ST investments | 42.70M | 65.17M | 98.51M |
| Inventory | 245.51M | 231.40M | 346.42M |
| Total assets | 1.11B | 1.09B | 2.01B |
| Total current liabilities | 267.49M | 267.22M | 461.25M |
| Short-term debt | 34.01M | 32.50M | 65.76M |
| Long-term debt | 416.51M | 376.59M | 548.05M |
| Total liabilities | 772,824,000.00 | 722,949,000.00 | 1,193,328,000.00 |
| Total equity | 337.96M | 365.18M | 814.95M |
| Retained earnings | 33.79M | 61.25M | 57.55M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 536.42M | 605.61M | 920.23M | 877.73M | 890.30M | 897.03M |
| Cash & ST investments | 47.82M | 63.58M | 125.97M | 98.51M | 115.89M | 109.73M |
| Inventory | 260.39M | 297.53M | 384.45M | 346.42M | 379.19M | 380.15M |
| Total assets | 1.12B | 1.22B | 2.08B | 2.01B | 2.01B | 2.02B |
| Total current liabilities | 258.16M | 308.49M | 437.84M | 461.25M | 448.44M | 452.60M |
| Short-term debt | 33.93M | 38.24M | 44.41M | 65.76M | 86.23M | 84.60M |
| Long-term debt | 402.44M | 440.98M | 628.36M | 548.05M | 560.96M | 551.34M |
| Total liabilities | 745,687,000.00 | 859,657,000.00 | 1,263,065,000.00 | 1,193,328,000.00 | 1,192,422,000.00 | 1,191,417,000.00 |
| Total equity | 371.40M | 359.20M | 812.30M | 814.95M | 814.69M | 824.29M |
| Retained earnings | 63.32M | 51.49M | 50.72M | 57.55M | 56.30M | 64.87M |
Cash flow
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating cash flow | 30.09M | 68.77M | 8.97M |
| Depreciation & amortization | 27.16M | 26.41M | 44.20M |
| Free cash flow | 18.18M | 55.16M | -5.27M |
| Dividends paid | -2.07M | -3.23M | -13.44M |
| Stock buybacks / issuance | 224.00K | -257.00K | 0 |
| Ending cash balance | 42.70M | 65.17M | 98.51M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -26.56M | 5.35M | -3.34M | 33.52M | -17.74M | 7.11M |
| Depreciation & amortization | 6.63M | 6.43M | 14.99M | 16.16M | 13.80M | 14.15M |
| Free cash flow | -29.68M | 3.24M | -8.57M | 29.74M | -19.67M | 4.45M |
| Dividends paid | 0 | -9.53M | -2.08M | -1.83M | -2.00M | -1.96M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 47.82M | 63.58M | 125.97M | 98.51M | 115.89M | 109.73M |
Returns & efficiency
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| ROE %i | 3.31 | 8.73 | 1.65 |
| ROA %i | 1.01 | 2.79 | 0.63 |
| ROIC %i | 4.22 | 6.67 | 3.83 |
| 5-year avg ROE %i | -- | -- | -- |
| EBIT margin %i | 5.45 | 6.98 | 3.47 |
| FCF / sales %i | 1.79 | 5.08 | -- |
| Current ratioi | 1.94 | 1.94 | 1.90 |
| Quick ratioi | 0.95 | 0.99 | 1.07 |
| Debt / assetsi | 45.88 | 42.44 | 37.75 |
| LT debt / equityi | 140.74 | 117.60 | 84.97 |
| Interest coveragei | 1.46 | 2.22 | 1.27 |
| Revenue CAGR (3Y) %i | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 6.47 | 3.77 | 1.29 | 1.65 | 1.41 | 3.58 |
| ROA %i | 2.15 | 1.11 | 0.50 | 0.63 | 0.54 | 1.31 |
| ROIC %i | 5.53 | 4.23 | 2.64 | 3.83 | 3.98 | 4.56 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 5.88 | 4.56 | 3.85 | 3.47 | 3.24 | 3.92 |
| FCF / sales %i | 3.25 | 3.89 | 1.13 | -- | 0.27 | 0.30 |
| Current ratioi | 2.08 | 1.96 | 2.10 | 1.90 | 1.99 | 1.98 |
| Quick ratioi | 0.95 | 0.90 | 1.16 | 1.07 | 1.04 | 1.06 |
| Debt / assetsi | 44.18 | 45.95 | 39.21 | 37.75 | 39.46 | 39.02 |
| LT debt / equityi | 123.77 | 145.31 | 94.73 | 84.97 | 86.64 | 85.16 |
| Interest coveragei | 2.01 | 1.53 | 1.32 | 1.27 | 1.20 | 1.58 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-09 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Aebi Schmidt discussion 0 comments